Requires other quality standards. In addition, in consideration of the applicable provisions of USP 797 concerning sterile preparations, Chapter 1075 of the USP-NF concerning good compounding practices, and Chapter 1160 of the USP-NF concerning pharmaceutical calculations, policies and procedures for the compounding or sterile prepackaging of drug products must ensure the safety, identity, strength, quality, and purity of the finished product.

COVID-19 Note: March 20, 2020 Update – BOP reiterates USP’s letter regarding use of enforcement discretion with USP standards during the COVID-19 pandemic.

Citations

Idaho Pharmacy Laws 1

Idaho Pharmacy Laws 2